APATH, LLC

Basic Information

APATH, LLC
893 N. WARSON RD.
SAINT LOUIS, MO, 63141

Company Profile

n/a

Additional Details

Field Value
DUNS: 75127220
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. The in vitro hepatitis C virus infection system as a drug discovery tool

    Amount: $100,713.00

    DESCRIPTION (provided by applicant): Hepatitis C virus (HCV) infection is a major cause of liver disease throughout the world. Existing therapies are suboptimal and the search for alternative therapie ...

    SBIR Phase I 2007 Department of Health and Human Services
  2. Filovirus drug discovery using novel combinations of approved drugs

    Amount: $749,926.00

    The goal of this proposal is to find novel combinations of approved drugs for the treatment and/or prevention of infection with filoviruses. Ebola and Marburg viruses, the only filoviruses, cause an ...

    SBIR Phase II 2006 Office for Chemical and Biological Defense Department of Defense
  3. Transgenic indicator cells for influenza virus

    Amount: $581,898.00

    DESCRIPTION (provided by applicant): Influenza virus causes a pandemic disease of the respiratory tract that results in significant human morbidity and mortality. Diagnosis of influenza virus infecti ...

    SBIR Phase II 2005 Department of Health and Human Services
  4. Filovirus drug discovery using novel combinations of approved drugs

    Amount: $99,999.00

    The goal of this proposal is find novel combinations of approved drugs for the treatment and/or prevention of infection with filoviruses. Ebola and Marburg viruses, the only filoviruses, cause an acu ...

    SBIR Phase I 2005 Office for Chemical and Biological Defense Department of Defense
  5. Indicator cells for antiviral screening for filoviruses

    Amount: $725,891.00

    DESCRIPTION (provided by applicant): Filoviruses include some of the most notorious human pathogens and cause significant morbidity and mortality due to severe hemorrhagic fever syndromes. Unfortunat ...

    SBIR Phase II 2004 Department of Health and Human Services
  6. Transgenic indicator cells for influenza virus

    Amount: $106,026.00

    DESCRIPTION (provided by applicant): Influenza virus causes a pandemic disease of the respiratory tract that results in significant human morbidity and mortality. Diagnosis of influenza virus infecti ...

    SBIR Phase I 2004 Department of Health and Human Services
  7. Molecular tools for Bunyavirus antiviral screening

    Amount: $741,038.00

    DESCRIPTION (provided by investigator): Several viruses in the family Bunyaviridae are significant human pathogens and potential agents of bioterrorism. Vaccines against some of these viruses do exist ...

    STTR Phase I 2004 Department of Health and Human Services
  8. Replicon-based screening for inhibitors of alphaviruses

    Amount: $958,581.00

    DESCRIPTION (provided by applicant): The goal in this study is to develop a cell-based assay to screen compounds for antiviral activity against certain members of the Togavirus family. We are particul ...

    SBIR Phase I 2004 Department of Health and Human Services
  9. Screening for anti-RSV compounds with indicator cells

    Amount: $0.00

    DESCRIPTION (provided by applicant): The goal of this project is to use an infection-independent cell-based assay to identify compounds that inhibit respiratory syncytial virus (RSV). The basis of t ...

    SBIR Phase I 2003 Department of Health and Human Services
  10. Screening for anti-RSV compounds with indicator cells

    Amount: $733,316.00

    DESCRIPTION (provided by applicant): The goal of this project is to use an infection-independent cell-based assay to identify compounds that inhibit respiratory syncytial virus (RSV). The basis of t ...

    SBIR Phase II 2003 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government